biote Corp.

BTMD

Current ValuationThe current P/E ratio is -20.16, below the reasonable range, cheaper than 95.15% of the time in the past 3 years, and the industry ranks 205/257, the industry Median -1.02.

-20.16xP/E
Stock price$1.08Earnings per share$-0.05

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
03876114152

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAYZFUSBayer Aktiengesellschaft
-37.44x--$62.24B
BAYRYUSBayer
-37.78x--$62.80B
VTRSUSViatris
-39.33x97.55%$23.90B
ELANUSElanco Animal Health
-90.99x146.23%$13.38B
ABVXUSAbivax SA
-16.87x22.99%$7.85B
AXSMUSAxsome Therap
-47.14x29.75%$7.42B
CURLFUSCuraleaf Holdings, Inc.
-331.19x--$6.84B
VREOFUSVIREO GROWTH INC
-94.54x--$6.35B
BLTEUSBelite Bio
-61.58x29.87%$6.30B
MANEUSVeraDermics
-57.98x97.44%$6.20B
DFTXUSDefinium Therapeutics
-13.79x43.38%$4.65B
LQDAUSLiquidia Tech
-48.85x354.53%$4.60B
AMLXUSAmylyx Pharmaceuticals
-24.35x1.63%$3.97B
ELVNUSEnliven Therapeutics
-33.20x2.84%$3.77B
TARSUSTarsus Pharmaceuticals
-5.18x879.07%$3.64B
BHCUSBausch Health
-3.69x511.90%$3.10B
XERSUSXeris Biopharma
-445.22x--$2.89B
MBXUSMBX Biosciences
-18.70x56.01%$2.71B
RGCUSRegencell Bioscience
-221.44x--$2.59B
SEPNUSSepterna
-41.41x56.82%$2.44B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.